Phase 2 study of pamiparib in chinese patients with advanced ovarian cancer

 Volver  Ver
Phase 2 study of pamiparib in chinese patients with advanced ovarian cancer
 POSTER   09/2020
 Download  Ver

Para obtener más información sobre esta publicación, por favor envíe una solicitud de información médica.

Rating

Rate this publication

Publicaciones relacionadas

BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer
BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer
BeiGene Clinical Pipeline - Solid Tumor
BeiGene Clinical Pipeline - Solid Tumor
Interactive pipeline
Interactive pipeline
 Volver